Antimicrobial Peptides Market Revenue 2024 to 2034
Antimicrobial Peptides Market Revenue 2024 to 2034
The Antimicrobial Peptides Market is projected to expand from USD 14.91 Bn in 2024 to USD 60.51 Bn by 2034, at a CAGR of 15.0%. Growth is fueled by rising antimicrobial resistance, increasing demand for novel therapeutics, and expanding applications in pharmaceuticals, agriculture, and food preservation.
Report ID: 10372
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 14.91 Bn
Forecast Year,
USD 60.51 Bn
CAGR, 2025 -
15.03%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Antimicrobial Peptides Market Size Analysis
Antimicrobial Peptides Market Size By Product & Service 2024 to 2034 (USD )
| Product & Service | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Products | 6.86 | 7.97 | 9.18 | 10.53 | 12.09 | 13.87 | 15.91 | 18.36 | 21.08 | 24.37 | 28.06 |
| Services | 5.37 | 6.11 | 7.04 | 8.10 | 9.35 | 10.73 | 12.36 | 14.17 | 16.32 | 18.65 | 21.50 |
| Software | 2.68 | 3.08 | 3.52 | 4.07 | 4.68 | 5.45 | 6.28 | 7.22 | 8.34 | 9.58 | 10.96 |
Antimicrobial Peptides Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical | 5.37 | 6.17 | 7.09 | 8.13 | 9.35 | 10.75 | 12.36 | 14.21 | 16.31 | 18.71 | 21.43 |
| Research | 4.18 | 4.79 | 5.50 | 6.33 | 7.27 | 8.33 | 9.55 | 11.03 | 12.78 | 14.77 | 16.99 |
| Operations | 3.58 | 4.14 | 4.79 | 5.52 | 6.36 | 7.36 | 8.48 | 9.72 | 11.10 | 12.72 | 14.70 |
| Others | 1.79 | 2.05 | 2.36 | 2.72 | 3.13 | 3.60 | 4.17 | 4.79 | 5.54 | 6.39 | 7.39 |
Antimicrobial Peptides Market Size By End-User 2024 to 2034 (USD )
| End-User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals/Providers | 6.26 | 7.24 | 8.33 | 9.54 | 11.01 | 12.68 | 14.52 | 16.72 | 19.22 | 21.94 | 25.26 |
| Pharma & Biotech | 3.88 | 4.46 | 5.13 | 5.93 | 6.81 | 7.82 | 9.06 | 10.46 | 12.10 | 14.04 | 16.07 |
| Payers/Govt | 1.79 | 2.04 | 2.36 | 2.74 | 3.13 | 3.61 | 4.16 | 4.77 | 5.47 | 6.30 | 7.27 |
| Academic/Research | 2.39 | 2.74 | 3.14 | 3.60 | 4.14 | 4.74 | 5.44 | 6.22 | 7.13 | 8.24 | 9.50 |
| Others | 0.60 | 0.68 | 0.78 | 0.90 | 1.03 | 1.19 | 1.38 | 1.59 | 1.82 | 2.09 | 2.41 |
Antimicrobial Peptides Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 5.67 | 6.55 | 7.51 | 8.64 | 9.88 | 11.37 | 13.04 | 15.06 | 17.33 | 19.99 | 23.08 |
| Europe | 4.18 | 4.79 | 5.53 | 6.37 | 7.36 | 8.47 | 9.80 | 11.30 | 13.01 | 14.88 | 16.98 |
| Asia Pacific | 3.88 | 4.45 | 5.12 | 5.86 | 6.77 | 7.79 | 8.94 | 10.22 | 11.77 | 13.57 | 15.65 |
| Latin America | 0.60 | 0.69 | 0.79 | 0.92 | 1.05 | 1.21 | 1.38 | 1.58 | 1.81 | 2.06 | 2.37 |
| Middle East & Africa | 0.60 | 0.68 | 0.79 | 0.91 | 1.05 | 1.20 | 1.39 | 1.60 | 1.82 | 2.11 | 2.43 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
